CLIP4 Activators
Chemical activators of CLIP4 function through a variety of mechanisms that orchestrate the protein's role in microtubule dynamics. Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C, which is known for its broad spectrum of target proteins. When PMA activates PKC, it can lead to the phosphorylation of CLIP4, which in turn might enhance its interaction with microtubules, thereby modulating the cytoskeleton's stability and dynamics. Similarly, Forskolin, by elevating intracellular cAMP levels, activates PKA, which can also phosphorylate CLIP4. This phosphorylation can alter CLIP4's role in the regulation of microtubule dynamics, which is crucial for maintaining cellular architecture. Bisindolylmaleimide I, although a selective inhibitor of PKC, can at low concentrations selectively activate certain PKC isoforms, potentially leading to the phosphorylation and subsequent activation of CLIP4. Additionally, 8-Bromo-cAMP, a cell-permeable analog of cAMP, activates PKA and may follow a similar pathway to phosphorylate and thereby regulate CLIP4 activity.
On the other end of the spectrum, substances like Calyculin A, Okadaic Acid, and Tautomycin act as inhibitors of protein phosphatases like PP1 and PP2A. Normally, these phosphatases would dephosphorylate CLIP4, but their inhibition results in the sustained phosphorylation and consequent activation of CLIP4. This persistent activation can affect CLIP4's interaction with the microtubule network, influencing cellular shape and motility. Ionomycin and Thapsigargin, by increasing intracellular calcium levels, can activate calcium/calmodulin-dependent protein kinases, which may phosphorylate CLIP4, affecting its role in microtubule stabilization. Staurosporine, a potent kinase inhibitor, can paradoxically activate kinases at low concentrations, which might result in the activation of CLIP4 through phosphorylation. These diverse chemicals, through their unique interactions with cellular signaling pathways, facilitate the modulation of CLIP4's activity, underscoring its integral role in microtubule dynamics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which is known to phosphorylate a wide array of target proteins. Since CLIP4 has been identified to interact with the cytoskeleton and is potentially regulated by phosphorylation, the activation of PKC by PMA can lead to the phosphorylation and functional activation of CLIP4 by promoting its association with microtubules or regulating its role in microtubule dynamics. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases PP1 and PP2A. The inhibition of these phosphatases by Calyculin A can result in an increased phosphorylation state of cellular proteins. CLIP4, which may be dephosphorylated by these phosphatases under normal conditions, would remain phosphorylated in their presence, thus maintaining its active state that is associated with its function in microtubule dynamics. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Similar to Calyculin A, Okadaic Acid is a potent inhibitor of protein phosphatases, specifically PP1 and PP2A. By inhibiting these phosphatases, Okadaic Acid causes a rise in the phosphorylation levels of many proteins. The sustained phosphorylation state can lead to the activation of CLIP4, promoting its functional role in the stabilization and organization of the microtubule network. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin functions as an ionophore for calcium, increasing intracellular calcium levels. Elevated calcium levels can activate calcium/calmodulin-dependent protein kinases (CaMKs), which in turn can phosphorylate and thereby activate CLIP4. This activation of CLIP4 would affect its role in the stabilization of microtubules and the regulation of their dynamics. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent, non-selective inhibitor of protein kinases. However, at low concentrations, it can act more selectively to activate certain kinases prior to inhibiting them. This initial activation could lead to the phosphorylation and activation of proteins like CLIP4, influencing its interactions with the microtubule cytoskeleton and its functions in cellular morphology and motility. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a selective inhibitor of PKC, but like staurosporine, at low concentrations, it may selectively activate certain PKC isoforms. This selective activation can potentially result in the phosphorylation and activation of CLIP4, modulating its role in microtubule stabilization and dynamics. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. Activation of PKA can lead to the phosphorylation of various substrates, which could include CLIP4. Such phosphorylation is likely to activate CLIP4's role in microtubule binding and regulation of microtubule dynamics, which is essential for the maintenance of cellular architecture. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor which leads to an increase in cytosolic calcium levels. This rise in calcium can activate CaMKs, which could phosphorylate CLIP4, thereby activating it. The activation of CLIP4 through this pathway would be essential for its role in microtubule stabilization and dynamics, impacting on cell shape and motility. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tautomycin is another inhibitor of protein phosphatases PP1 and PP2A. Inhibition of these phosphatases by Tautomycin would prevent the dephosphorylation of CLIP4, potentially leading to its sustained activation. This continued activation of CLIP4 would promote its role in microtubule dynamics and cellular morphology. | ||||||